Steve Sosnick, Interactive Brokers’ chief strategist, discusses the latest vaccine news from Astra-Zeneca and Oxford University.
With each new vaccine development, the stock market dynamics are changing, according to Sosnick. Here’s why:
Photo Credit: Yuri Samoilov via Flickr Creative Commons
Nike’s (NKE) Q4 earnings on Thursday afternoon were poor on many fronts, notes Scott Rubin at Benzinga. It may be pointing to trouble in the retail sector.
Emerging market investors are rushing to the exits.
The S&P 500 dropped more than 1% on Friday as oil prices surged and the job report came in well below estimates. An open around $95 for oil would place it at its next level of resistance and its highest price since September 2023.
The data and chart are from the United Nations. Bill Luby adds some detail on the rising prices: Among the various sub-indices, […]
